Epirubicin

Epirubicin2DACS

Epirubicin ball-and-stick

Epirubicin is an anthracycline antibiotic used in cancer chemotherapy. It is a derivative of doxorubicin and is primarily used to treat breast cancer. Epirubicin works by interfering with the DNA replication process, thereby inhibiting the growth and proliferation of cancer cells.

Mechanism of Action

Epirubicin exerts its effects by intercalating into DNA strands, which disrupts the enzyme topoisomerase II and prevents the DNA from being replicated. This leads to cell death in rapidly dividing cells, such as cancer cells.

Uses

Epirubicin is used in the treatment of various types of cancer, including:

• Breast cancer
• Gastric cancer
• Ovarian cancer
• Lung cancer

Administration

Epirubicin is administered intravenously. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and other factors. It is often used in combination with other chemotherapy agents.

Side Effects

Common side effects of epirubicin include:

• Nausea and vomiting
• Hair loss
• Myelosuppression (decreased production of blood cells)
• Cardiotoxicity (damage to the heart muscle)

Precautions

Patients receiving epirubicin should be monitored for signs of cardiotoxicity, and regular blood tests should be conducted to check for myelosuppression. It is also important to avoid pregnancy while undergoing treatment with epirubicin.

Related Pages

• Chemotherapy
• Breast cancer
• Doxorubicin
• Topoisomerase II
• DNA replication